It is my understanding that the Clinical Trial Number should populate in 2300 REF Demonstration Project Identifier//REF02 where 2300/REF01 =P4 on the 837..
I have also seen documentation indicating that the Clinical Trial Number should populate in the 2300/HI - Value Information segment with qualifier BE, however, it seems that this may have been an older requirement.
My questions are is it only required to populate in the REF Demonstration Project Identifier / REF02 segment and if so, if it is also found in the 2300/HI - Value Information segment would the claim reject?
The 2300 REF Demonstration Project Identifier is “ Required when it is necessary to identify claims which are atypical in ways such as content, purpose, and/or payment, as could be the case for a demonstration or other special project, or a clinical trial. If not required by this implementation guide, do not send.” Therefore, the Clinical Trial Number must be sent in this segment when it is necessary to identify the claim as such.
The 2300 HI - Value Information segment is “Required when there is a Value Code that applies to this claim. If not required by this implementation guide, do not send.” Please review the NUBC Official UB-04 Data Specifications Manual for instructions related to the Clinical Trial Number Value Code.
ASC X12 does not govern or take a position on the receiver’s action when receiving a transaction.